dockets
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
261 rows where agency_id = "DEA" and docket_type = "Rulemaking" sorted by last_modified descending
This data as json, CSV (advanced)
Suggested facets: last_modified (date)
| id | agency_id | title | docket_type | last_modified ▲ | object_id |
|---|---|---|---|---|---|
| DEA_FRDOC_0001 | DEA | Recently Posted DEA Rules and Notices | Rulemaking | 2026-03-10T12:55:22Z | 0b0000648025b551 |
| DEA-2023-0057 | DEA | Definition of ‘‘Cannabimimetic Agents’’ and Assignment of an Administration Controlled Substances Code Number for All ‘‘Cannabimimetic Agents’’ (DEA368) | Rulemaking | 2026-01-20T18:44:45Z | 0b00006485945c83 |
| DEA-2026-0133 | DEA | Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442) | Rulemaking | 2026-01-20T18:39:12Z | 0b000064b9161bed |
| DEA-2025-0075 | DEA | Placement of 4-Fluoroamphetamine in Schedule I (DEA1180) | Rulemaking | 2026-01-16T15:16:59Z | 0b000064b8dc49a1 |
| DEA-2023-0029 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) | Rulemaking | 2026-01-12T22:00:12Z | 0b00006485728671 |
| DEA-2024-0118 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337) | Rulemaking | 2026-01-12T21:58:59Z | 0b00006486732eab |
| DEA-2023-0147 | DEA | Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143) | Rulemaking | 2026-01-05T20:10:17Z | 0b0000648613cdb2 |
| DEA-2025-0852 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) | Rulemaking | 2026-01-05T13:16:32Z | 0b000064b90c539c |
| DEA-2025-0918 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) | Rulemaking | 2026-01-05T13:16:18Z | 0b000064b90dd26c |
| DEA-2025-0654 | DEA | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026 | Rulemaking | 2025-12-16T20:07:46Z | 0b000064b909f13a |
| DEA-2025-0885 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) | Rulemaking | 2025-12-15T15:47:54Z | 0b000064b90d3674 |
| DEA-2025-0555 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) | Rulemaking | 2025-12-11T14:41:46Z | 0b000064b8fefe20 |
| DEA-2024-0144 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) | Rulemaking | 2025-11-19T21:13:12Z | 0b00006486891ffe |
| DEA-2025-0557 | DEA | Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395) | Rulemaking | 2025-11-04T12:07:45Z | 0b000064b8fefe8d |
| DEA-2025-0588 | DEA | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494) | Rulemaking | 2025-10-16T23:33:17Z | 0b000064b9030281 |
| DEA-2025-0192 | DEA | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) | Rulemaking | 2025-10-16T23:28:47Z | 0b000064b8ec6630 |
| DEA-2023-0016 | DEA | Controlled Substances Ordering System Modernization (DEA732) | Rulemaking | 2025-10-02T21:31:46Z | 0b0000648562ccb3 |
| DEA-2025-0558 | DEA | Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111) | Rulemaking | 2025-10-02T21:30:04Z | 0b000064b8fefe93 |
| DEA-2024-0148 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) | Rulemaking | 2025-10-02T21:28:47Z | 0b00006486894bb0 |
| DEA-2025-0556 | DEA | Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical | Rulemaking | 2025-10-02T21:22:21Z | 0b000064b8fefe24 |
| DEA-2024-0120 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025 | Rulemaking | 2025-09-19T16:15:52Z | 0b00006486783c5d |
| DEA-2022-0145 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) | Rulemaking | 2025-08-27T12:33:24Z | 0b0000648554cfe6 |
| DEA-2024-0026 | DEA | Placement of 2-Methyl AP-237 in Schedule I (DEA1245) | Rulemaking | 2025-07-28T18:22:10Z | 0b00006486484632 |
| DEA-2023-0148 | DEA | Destruction Alternatives to Incineration (DEA1144) | Rulemaking | 2025-07-28T18:21:23Z | 0b0000648618d50c |
| DEA-2025-0078 | DEA | Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484) | Rulemaking | 2025-07-28T18:18:20Z | 0b000064b8dd586c |
| DEA-2023-0138 | DEA | Designation of Propionyl Chloride as a List I Chemical (DEA1189) | Rulemaking | 2025-07-10T12:04:03Z | 0b000064860bbba7 |
| DEA-2025-0081 | DEA | Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146) | Rulemaking | 2025-07-10T11:56:30Z | 0b000064b8ddd142 |
| DEA-2023-0098 | DEA | Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481) | Rulemaking | 2025-07-07T16:45:39Z | 0b00006485d9c470 |
| DEA-2021-0003 | DEA | Suspicious Orders of Controlled Substances | Rulemaking | 2025-06-05T16:32:03Z | 0b000064849e1a2e |
| DEA-2023-0028 | DEA | Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) | Rulemaking | 2025-06-02T20:11:54Z | 0b0000648572859f |
| DEA-2024-0059 | DEA | Schedules of Controlled Substances: Rescheduling of Marijuana | Rulemaking | 2025-02-21T15:51:02Z | 0b0000648656cd99 |
| DEA-2023-0168 | DEA | Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156) | Rulemaking | 2025-02-21T15:50:53Z | 0b00006486330ce3 |
| DEA-2023-0150 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (DEA1228) | Rulemaking | 2025-02-21T15:50:43Z | 0b000064861df091 |
| DEA-2024-0134 | DEA | Control of Phenethyl Bromide as a List I Chemical (DEA1282) | Rulemaking | 2025-01-07T09:13:06Z | 0b0000648683d06e |
| DEA-2021-0031 | DEA | Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I | Rulemaking | 2024-10-25T14:56:30Z | 0b00006484ea7ed9 |
| DEA-2023-0129 | DEA | Placement of Ethylphenidate in Schedule I (DEA1142) | Rulemaking | 2024-10-24T10:27:34Z | 0b00006485fe80fd |
| DEA-2023-0149 | DEA | Placement of Zuranolone in Schedule IV (DEA1258) | Rulemaking | 2024-09-03T18:47:04Z | 0b000064861a0975 |
| DEA-2022-0058 | DEA | Providing CS to Ocean Vessels, Aircraft, and Other Entities | Rulemaking | 2024-08-26T13:13:33Z | 0b0000648514e942 |
| DEA-2024-0009 | DEA | Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014 | Rulemaking | 2024-08-26T13:13:33Z | 0b000064863e8464 |
| DEA-2021-0027 | DEA | Regulation of Telepharmacy Practice | Rulemaking | 2024-08-26T13:06:55Z | 0b00006484e57207 |
| DEA-2020-0023 | DEA | Implementation of the Agricultural Improvement Act | Rulemaking | 2024-08-26T13:03:33Z | 0b0000648481bb3b |
| DEA-2020-0031 | DEA | Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment | Rulemaking | 2024-08-26T13:03:21Z | 0b00006484946331 |
| DEA-2020-0029 | DEA | Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 | Rulemaking | 2024-08-26T13:02:59Z | 0b000064848b8dbc |
| DEA-2010-0010 | DEA | Electronic Prescriptions for Controlled Substances | Rulemaking | 2024-08-26T13:00:45Z | 0b00006480acce59 |
| DEA-2021-0005 | DEA | Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration | Rulemaking | 2024-07-12T12:24:57Z | 0b000064849e58a9 |
| DEA-2021-0009 | DEA | MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine | Rulemaking | 2024-06-11T01:13:26Z | 0b00006484aeb507 |
| DEA-2022-0120 | DEA | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023 | Rulemaking | 2024-02-12T10:32:02Z | 0b000064854169b8 |
| DEA-2023-0169 | DEA | Specific Listing for Three Currently Controlled Schedule I Substances (DEA1222) | Rulemaking | 2024-02-12T10:29:05Z | 0b00006486330ce7 |
| DEA-2023-0049 | DEA | Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006) | Rulemaking | 2023-12-12T10:13:43Z | 0b000064858c4370 |
| DEA-2023-0058 | DEA | Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036) | Rulemaking | 2023-12-07T08:20:24Z | 0b00006485946204 |
| DEA-2023-0146 | DEA | Additions to Listing of Exempt Chemical Mixtures (DEA1118) | Rulemaking | 2023-11-28T08:25:33Z | 0b00006486128852 |
| DEA-2023-0059 | DEA | Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098) | Rulemaking | 2023-10-31T09:33:44Z | 0b00006485948761 |
| DEA-2023-0106 | DEA | Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (DEA702) | Rulemaking | 2023-09-22T15:24:15Z | 0b00006485e04d45 |
| DEA-2019-0013 | DEA | Management of Quotas for Controlled Substances and List I Chemicals | Rulemaking | 2023-08-31T08:33:18Z | 0b000064840ecddb |
| DEA-2021-0026 | DEA | Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling | Rulemaking | 2023-07-27T17:35:24Z | 0b00006484e3d5e0 |
| DEA-2020-0035 | DEA | Partial Filling of Prescriptions for Schedule II Controlled Substances | Rulemaking | 2023-07-21T08:48:17Z | 0b0000648498d6d9 |
| DEA-2020-0038 | DEA | Schedules of Controlled Substances: Placement of Brorphine in Schedule I | Rulemaking | 2023-07-19T11:16:28Z | 0b000064849c2716 |
| DEA-2020-0022 | DEA | Reporting of Theft or Significant Loss of Controlled Substances | Rulemaking | 2023-06-22T11:34:57Z | 0b000064847f5109 |
| DEA-2023-0056 | DEA | Specific Listing for Eutylone, a Currently Controlled Schedule I Substance (DEA1003) | Rulemaking | 2023-04-20T11:59:12Z | 0b0000648591cd29 |
| DEA-2022-0102 | DEA | Designation of 4-Piperidone as a List I Chemical (DEA951) | Rulemaking | 2023-04-14T08:25:52Z | 0b0000648532a5f2 |
| DEA-2021-0013 | DEA | Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I | Rulemaking | 2023-01-03T10:35:25Z | 0b00006484d9d986 |
| DEA-2022-0137 | DEA | Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023 | Rulemaking | 2022-12-02T09:49:04Z | 0b00006485511272 |
| DEA-2020-0027 | DEA | Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration | Rulemaking | 2022-11-30T08:08:19Z | 0b000064848ac79e |
| DEA-2021-0012 | DEA | Schedules of Controlled Substances: Placement of Mesocarb in Schedule I | Rulemaking | 2022-11-22T08:27:38Z | 0b00006484c6c390 |
| DEA-2021-0025 | DEA | Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control | Rulemaking | 2022-11-21T08:32:10Z | 0b00006484e16b15 |
| DEA-2020-0015 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I | Rulemaking | 2022-11-21T08:31:59Z | 0b000064846acf98 |
| DEA-2021-0011 | DEA | Schedules of Controlled Substances: Placement of Amineptine in Schedule I | Rulemaking | 2022-11-17T08:07:18Z | 0b00006484c12765 |
| DEA-2022-0134 | DEA | Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical (DEA1046) | Rulemaking | 2022-11-14T08:34:19Z | 0b0000648549e00d |
| DEA-2022-0133 | DEA | Technical Correction to Regulation Regarding Registration Exception for Officials | Rulemaking | 2022-11-07T09:10:13Z | 0b000064854931e9 |
| DEA-2021-0014 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022 | Rulemaking | 2022-11-01T08:26:20Z | 0b00006484dc7d4f |
| DEA-2022-0025 | DEA | Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV | Rulemaking | 2022-09-30T08:21:23Z | 0b00006484fff734 |
| DEA-2022-0026 | DEA | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I | Rulemaking | 2022-09-13T08:49:45Z | 0b0000648500a875 |
| DEA-2022-0001 | DEA | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I | Rulemaking | 2022-07-27T08:21:18Z | 0b00006484f21216 |
| DEA-2021-0010 | DEA | Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV | Rulemaking | 2022-06-24T08:22:18Z | 0b00006484b1ab60 |
| DEA-2022-0027 | DEA | Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products | Rulemaking | 2022-06-07T08:46:48Z | 0b0000648500f7d4 |
| DEA-2021-0030 | DEA | Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I | Rulemaking | 2022-06-06T09:58:53Z | 0b00006484ea7ed5 |
| DEA-2019-0002 | DEA | Schedules of Controlled Substances: Placement of 5F-EDMBPINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I | Rulemaking | 2022-04-08T08:28:19Z | 0b00006483b714a4 |
| DEA-2018-0002 | DEA | Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder | Rulemaking | 2022-04-02T01:07:02Z | 0b00006482e4b773 |
| DEA-2018-0009 | DEA | Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I | Rulemaking | 2022-04-02T01:07:02Z | 0b00006483254c72 |
| DEA-2014-0005 | DEA | Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II | Rulemaking | 2022-03-22T11:18:07Z | 0b000064815b6cb3 |
| DEA-2018-0004 | DEA | Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U–47700 Into Schedule I (DEA-478) | Rulemaking | 2022-03-22T11:16:58Z | 0b0000648319a695 |
| DEA-2021-0024 | DEA | Adding Space Force to DEA Regulations | Rulemaking | 2021-12-13T15:38:43Z | 0b00006484e0408e |
| DEA-2020-0036 | DEA | Supplier's Registration Number on the Single-Sheet DEA Form 222 | Rulemaking | 2021-12-13T15:35:55Z | 0b000064849af553 |
| DEA-2020-0005 | DEA | Registration Requirements for Narcotic Treatment Programs with Mobile Components | Rulemaking | 2021-12-13T15:33:40Z | 0b000064843b54e5 |
| DEA-2013-0002 | DEA | Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV | Rulemaking | 2021-12-02T01:01:29Z | 0b000064812438ed |
| DEA-2013-0009 | DEA | Schedules of Controlled Substances: Placement of Perampanel into Schedule III | Rulemaking | 2021-12-02T01:01:29Z | 0b000064814577a1 |
| DEA-2013-0010 | DEA | Schedules of Controlled Substances: Placement of Tramadol into Schedule IV | Rulemaking | 2021-12-02T01:01:29Z | 0b0000648146f62c |
| DEA-2013-0011 | DEA | Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines into Schedule I | Rulemaking | 2021-12-02T01:01:29Z | 0b0000648147da34 |
| DEA-2018-0006 | DEA | Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act, DEA-345 | Rulemaking | 2021-12-02T01:01:29Z | 0b0000648321a7cd |
| DEA-2019-0007 | DEA | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control | Rulemaking | 2021-12-02T01:01:29Z | 0b00006483eaf996 |
| DEA-2019-0003 | DEA | Interlocutory Appeals in Administrative Hearings | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483c17ccc |
| DEA-2019-0004 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483c8ada8 |
| DEA-2019-0009 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483f91d72 |
| DEA-2019-0010 | DEA | Listing of Noroxymorphone in the Code of Federal Regulations and Assignment of a Controlled Substances Code Number | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483f94f85 |
| DEA-2019-0011 | DEA | Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483f94f89 |
| DEA-2019-0012 | DEA | Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483f94f8d |
| DEA-2019-0014 | DEA | Schedules of Controlled Substances: Placement of Cyclopropyl Fentanyl, Methoxyacetyl fentanyl, ortho-Fluorofentanyl, and para-Fluorobutyryl Fentanyl in Schedule I | Rulemaking | 2021-12-02T01:00:59Z | 0b000064841fc599 |
| DEA-2020-0004 | DEA | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control | Rulemaking | 2021-12-02T01:00:59Z | 0b00006484322c50 |
| DEA-2020-0014 | DEA | Technical Correction to Regulation Regarding Registration | Rulemaking | 2021-12-02T01:00:59Z | 0b000064844bd097 |
| DEA-2020-0017 | DEA | Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I | Rulemaking | 2021-12-02T01:00:59Z | 0b000064846f9f29 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE dockets (
id TEXT PRIMARY KEY,
agency_id TEXT,
title TEXT,
docket_type TEXT,
last_modified TEXT,
object_id TEXT
);
CREATE INDEX idx_dockets_agency ON dockets(agency_id);
CREATE INDEX idx_dockets_type ON dockets(docket_type);